Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the vulnerable college transition period. Digital tools like this show promise because they can scale broadly and be tailored to student needs. Results from this trial offer direct evidence on whether app-based support can produce measurable improvements in mental health and substance use outcomes in a real-world university population.
#5 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides empirical evidence for the effectiveness of a student-centered digital intervention during a critical developmental window when mental health and substance use disorders frequently emerge. The study’s findings are clinically significant because they demonstrate whether scalable mobile health solutions can deliver meaningful outcomes for prevention and early intervention in university populations, potentially addressing gaps in access to traditional mental health services. The codevelopment approach with end users strengthens the clinical relevance by ensuring the intervention addresses actual student needs and barriers to care engagement.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 While the Minder app shows promise as a scalable digital intervention for university students navigating mental health and substance use challenges during a developmentally vulnerable period, several important caveats warrant consideration before clinical adoption. The study’s reliance on self-reported outcomes, potential selection bias from students willing to engage with mobile interventions, and lack of long-term follow-up data limit our ability to assess durability and real-world effectiveness across diverse student populations. Additionally, the codevelopment process with students, while enhancing acceptability, may not adequately address the needs of those with more severe psychiatric symptoms or those who lack digital literacy or consistent smartphone access. Rather than viewing Minder as a standalone treatment, clinicians might most responsibly integrate it as a complementary tool within a broader mental health framework, particularly for engaged students with mild to moderate symptoms, while ensuring that vulnerable students receive direct clinical assessment and care regardless of app engagement.